About
Ketamine derivative
Areas of Focus
Categories
Small Molecule PharmaceuticalPsychedelicNJ, NY, PA
Clinical Trials (2)
View allTotal Trials
2
As Lead Sponsor
1
As Collaborator
1
Total Enrollment
105
By Phase
PHASE2: 1
By Status
COMPLETED: 2
Clinical Trials Pipeline2 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2021
2022
2023
2024
2025
Today
Hover over trial bars to see details
Recent Trials
NCT06232291Collaborator
Observation of Safety and Tolerability Within 1 Year of the Use of R-ketamine / Placebo in Drug-resistant Depression
N/ACompleted
3 participants
Started: Apr 21, 2023 · Completed: May 24, 2024
NCT05414422Lead Sponsor
A Randomized, Placebo-Controlled, Double-Blind Study to Assess Safety and Efficacy of PCN-101 in TRD
PHASE2Completed
102 participants
Started: Feb 1, 2022 · Completed: Nov 10, 2022
Locations (1)
Headquarters
New York, NY, United States
Map
Loading map...